Home / Import refusals / WYX-2013003-5/1/1

FDA Import Refusal WYX-2013003-5/1/1 — Mayinglong Pharmaceutical Group Co., Ltd.

Mayinglong Pharmaceutical Group Co., Ltd. — FEI 3004363818

The FDA refused shipment WYX-2013003-5/1/1 from Mayinglong Pharmaceutical Group Co., Ltd. (China) on June 20, 2013. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
June 20, 2013
Country
China
Product Category
Drugs and Biologics
Product Code
66V99 MISCELLANEOUS PATENT MEDICINES, ETC.
Charges
75

Recent inspections

  • 1264613 (VAI Fri Mar 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1051249 (VAI Fri Apr 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 955742 (VAI Fri Dec 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 9H3-0003757-3/31/1M (Wed Oct 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • BXM-0013461-8/3/1 (Wed Aug 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 349-0971653-1/2/1 (Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 349-0971653-1/2/2 (Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 349-0971653-1/2/3 (Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources